| Preferred Name |
Essential Thrombocythemia |
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C3407 |
| ALT_DEFINITION |
An increased number of thrombocytes (platelets) in the blood, without a known cause. A chronic condition that involves primarily the megakaryocytic lineage. It is characterized by sustained thrombocytosis in the blood, increased numbers of large, mature megakaryocytes in the bone marrow, and elevated risk for thrombosis and/or hemorrhage. |
| code |
C3407 |
| Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C193248 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C126659 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C168661 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C158520 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116977 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C103126 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C168655 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C193231 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C193006 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C177537 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C168657 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C156966 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157711 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C118168 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C192842 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C165258 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C90259 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C156952 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C102905 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C193249 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C168662 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C132009 |
| Contributing_Source |
CPTAC NICHD mCode CTEP CTRP GDC Cellosaurus |
| DEFINITION |
A chronic myeloproliferative neoplasm that involves primarily the megakaryocytic lineage. It is characterized by sustained thrombocytosis in the blood, increased numbers of large, mature megakaryocytes in the bone marrow, and episodes of thrombosis and/or hemorrhage. (WHO, 2008) |
| Display_Name |
Essential Thrombocythemia |
| FULL_SYN |
Essential Thrombocythemia Essential (hemorrhagic) thrombocythemia Essential Thrombocytosis Essential thrombocythemia Essential Thrombocytemia Primary Thrombocytosis Idiopathic thrombocythemia Primary Thrombocythemia ET essential thrombocytosis Idiopathic Thrombocythemia essential thrombocythemia |
| ICD-O-3_Code |
9962/3 |
| Is_Value_For_GDC_Property | |
| label |
Essential Thrombocythemia |
| Legacy Concept Name |
Essential_Thrombocythemia |
| Maps_To |
Essential thrombocythemia Idiopathic hemorrhagic thrombocythaemia Idiopathic thrombocythemia 9962/3 Essential (haemorrhagic) thrombocythaemia Essential hemorrhagic thrombocythaemia |
| Neoplastic_Status |
Malignant |
| Preferred_Name |
Essential Thrombocythemia |
| prefixIRI |
Thesaurus:C3407 |
| prefLabel |
Essential Thrombocythemia |
| Semantic_Type |
Neoplastic Process |
| UMLS_CUI |
C0040028 |
| subClassOf |